Event: 11th Annual Global Summit on Hematologic Malignancies Location: Whistler, BC, CA Presentation: April 5, 2024 at 7:35 AM PT Presenter: Jelle Kylstra, M.D.
11th Annual Global Summit on Hematologic Malignancies
read more
News & Events
Sign-up for News Updates
News, Events & Presentations
Immuno-Oncology 360° Summit – February 28, 2024
Location: Brooklyn, NY Date: February 28, 2024 at 10:25 AM ET Presenter: Nathanael McCurley, Ph.D.
BIO CEO & Investor Conference – February 26, 2024
Location: New York, NY Date: February 26, 2024 at 2:30 PM ET Presenter: Robert Towarnicki
65th American Society of Hematology (ASH) Annual Meeting and Exposition
Event: 65th American Society of Hematology (ASH) Annual Meeting and Exposition Location: San Diego, CA Presentation: December 11, 2023 at 6:00 PM PT Presenters: Nathanael McCurley, Ph.D., Koby Kidder, Ph.D., Rita Bárcia, Ph.D. and Jelle Kylstra, M.D. Abstract Number:...
5th Macrophage-Directed Therapies Summit in Boston, MA
Location: Boston, MA Dates: November 13–15, 2023 Presenter: Nathanael McCurley
Society for Immunotherapy of Cancer 38th Annual Meeting
Location: San Diego, California SIRPant Speakers: Koby Kidder, Rita N. Bárcia, Nathanael McCurley Date: November 3, 2023, 9 a.m. PT / 12:00 p.m. ET Abstract Number: 685 Poster Title: A First-in-human Phase 1 clinical trial of SIRlow activated macrophages (SIRPant-M)...
SIRPant Immunotherapeutics Appoints Jelle Kijlstra, MD, MBA as Chief Medical Officer
Accomplished healthcare executive brings extensive drug development and regulatory experience from global CRO and multiple pharmaceutical companies to SIRPant Immunotherapeutics Inc (Hummelstown, July 11, 2023), SIRPant Immunotherapeutics Inc, a clinical-stage...
SIRPant Immunotherapeutics Announces FDA Clearance of IND Application for SIRPant-M™ Autologous SIRPαlow Activated Macrophage Immunotherapy
Hummelstown, PA — SIRPant Immunotherapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) cleared an investigational new drug (IND)...
IO360º Biotech Showcase – February 7-10, 2023
February 7-10, 2023 Speaking – Rita N. Bárcia, PhD, VP, Process Development & Operations LEARN MORE >
Macrophage-Directed Therapies Summit – October 4–6, 2022
October 4–6, 2022 Speaking – Rita N. Bárcia, PhD, VP, Process Development & Operations We’re proud to announce that Rita N. Bárcia, PhD, vice president of process development and operations, will be a presenter at this leading industry-focused forum uniting an...